Skip to main content
Moonjung Jung, MD, Hematology, Baltimore, MD

MoonjungJungMD

Hematology Baltimore, MD

Hematologic Oncology

Instructor in Clinical Investigation

Dr. Jung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jung's full profile

Already have an account?

  • Office

    4940 Eastern Avenue
    Baltimore, MD 21224
    Phone+1 410-550-0100
    Fax+1 410-550-0101

Summary

  • Dr. Moonjung Jung is a hematologist in Baltimore, MD and is affiliated with the Johns Hopkins Hospital. She received her medical degree from Ewha Womans University College of Medicine and has been in practice 10 years. She also speaks multiple languages, including Korean.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Methodist Hospital (Houston)
    Methodist Hospital (Houston)Residency, Internal Medicine, 2009 - 2012
  • Ewha Women's University College of Medicine
    Ewha Women's University College of MedicineClass of 2007

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2011 - 2026
  • NY State Medical License
    NY State Medical License 2016 - 2021
  • DC State Medical License
    DC State Medical License 2015 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Scholar Award in Basic/Translational Research ASH
  • Pilot Project Award NCATS/NIH, 2016-2019
  • Dean’s list College of Medicine, Ewha Womans University, 2001-2007
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Adaptive NK cells can persist in patients with GATA2 mutation depleted of hematopoietic stem and progenitor cells  
    Schlums H, Jung M, Han H, Theorell J, Bigley V, Chiang SC et al, Blood, 1/1/2017
  • Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers  
    Hong SG, Yada RC, Choi K, Carpentier A, Liang TJ, Merling RK, Sweeney CL, Malech HL, Jung M et al, Molecular Therapy, 1/1/2017
  • Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering  
    Jung M, Dunbar CE and Winkler T, Molecular Therapy, 1/1/2015
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Clinical severity correlates with in vitro residual function of FANCB missense variants
    Jung M, Ramanagoudr Bhojappa R, Rosti O, Lach FP, Donovan FX, Auerbach AD, et al, Fanconi Anemia Research Fund Annual Symposium, Newport Beach, CA, 1/1/2018
  • The Clinical and Hematologic Course of Fanconi Anemia Amongst Affected Siblings
    Jung M, Rosti O, Jiang CS, Correa da Rosa J, Smogorzewska A, Boulad F, Fanconi Anemia Research Fund Annual Symposium/American Society of Hematology, the 59th Annual Meeting, Atlanta, GA, 1/1/2017
  • Specific Impaired CD56+ NK Cell Development in GATA2 Deficiency As Revealed By Ex Vivo NK Expansion
    American Society of Hematology, the 56th Annual Meeting, San Francisco, CA, 1/1/2014
  • Join now to see all

Lectures

  • Induced pluripotent stem cells from a patient with GATA2 deficiency display a block in hematopoietic differentiation 
    Bethesda, MD - 1/1/2014
  • Surgical abdomen in a patient with CLL 
    Houston, TX - 1/1/2011

Professional Memberships

Other Languages

  • Korean